FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Indu Verma

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Javaid A Sheikh; Gopal K Khuller; Indu Verma
Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy.
Mamta Kalra; Gopal Krishan Khuller; Ajay Grover; Digambar Behera; Ajay Wanchu; Indu Verma
Utility of a combination of RD1 and RD2 antigens as a diagnostic marker for tuberculosis.
Indu Verma; Ajay Grover
Antituberculous vaccine development: a perspective for the endemic world.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Indu Verma (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Javaid A Sheikh; Gopal K Khuller; Indu Verma
Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy.
Journal of immune based therapies and vaccines 2011;9():4.
2010: Mamta Kalra; Gopal Krishan Khuller; Ajay Grover; Digambar Behera; Ajay Wanchu; Indu Verma
Utility of a combination of RD1 and RD2 antigens as a diagnostic marker for tuberculosis.
Diagnostic microbiology and infectious disease 2010;66(2):153-61.
2009: Indu Verma; Ajay Grover
Antituberculous vaccine development: a perspective for the endemic world.
Expert review of vaccines 2009;8(11):1547-53.
2007: Mamta Kalra; Ajay Grover; Neena Mehta; Jaspreet Singh; Jyotdeep Kaur; Suraj B Sable; Digambar Behera; Pawan Sharma; Indu Verma; Sudhir Sharma
Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice.
Clinical immunology (Orlando, Fla.) 2007;125(2):173-83.
2007: Suraj B Sable; Mamta Kalra; Indu Verma; Sudhir Sharma
Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
Clinical immunology (Orlando, Fla.) 2007;122(3):239-51.
2007: Suraj B Sable; D Goyal; Indu Verma; Digambar Behera; Sudhir Sharma
Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2007;29(2):337-46.
2006: Pramod K Giri; Indu Verma; Sudhir Sharma
Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
The Journal of infection 2006;53(5):350-6.
2006: Ajay Grover; Mir Fayaz Ahmed; Balwan Singh; Indu Verma; Pawan Sharma; Sudhir Sharma
A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens.
Microbes and infection / Institut Pasteur 2006;8(9-10):2390-9.
2006: Ajay Grover; Mir Fayaz Ahmed; Indu Verma; Pawan Sharma; Sudhir Sharma
Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immunoprophylactic potential in mouse model.
Protein expression and purification 2006;48(2):274-80.
2006: Pramod K Giri; Indu Verma; Sudhir Sharma
Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration.
FEMS immunology and medical microbiology 2006;47(2):233-41.
2005: Suraj B Sable; Sukhwinder Kaur; Indu Verma; Sudhir Sharma
Immunodominance of low molecular weight secretory polypeptides of Mycobacterium tuberculosis to induce cytotoxic T-lymphocyte response.
Vaccine 2005;23(41):4947-54.
2005: Suraj B Sable; Indu Verma; Sudhir Sharma
Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis.
Vaccine 2005;23(32):4175-84.
2005: Pramod K Giri; Suraj B Sable; Indu Verma; Sudhir Sharma
Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis.
FEMS immunology and medical microbiology 2005;45(1):87-93.
2005: Suraj B Sable; Rajnish Kumar; Mamta Kalra; Indu Verma; G K Khuller; Karen M Dobos; John Belisle
Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis.
Infection and immunity 2005;73(6):3547-58.
2005: Suraj B Sable; Indu Verma; Digambar Behera; Sudhir Sharma
Human immune recognition-based multicomponent subunit vaccines against tuberculosis.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2005;25(5):902-10.
2004: Anjana Kalita; Indu Verma; Sudhir Sharma
Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy.
The Journal of infectious diseases 2004;190(8):1476-80.
2004: Indu Verma; Rajesh Pandey; Sudhir Sharma
Liposomes as adjuvant for anti-mycobacterial vaccine development.
Indian journal of experimental biology 2004;42(10):949-54.
2001: D Kaur; Indu Verma; Sudhir Sharma
Biochemical effects of sparfloxacin on cell envelope of mycobacteria.
Indian journal of biochemistry & biophysics 2001;38(4):235-40.
2001: D Kaur; Indu Verma; Sudhir Sharma
Biochemical mechanism of combined effect of ethambutol and sparfloxacin against Mycobacterium smegmatis.
Indian journal of experimental biology 2001;39(3):238-42.
2001: Sudhir Sharma; Indu Verma; Gopal K Khuller
Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis.
Antimicrobial agents and chemotherapy 2001;45(2):639-40.
2000: S Sharma; Indu Verma; Sudhir Sharma
Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2000;16(1):112-7.
1999: A K Sharma; Indu Verma; R Tewari; Sudhir Sharma
Adjuvant modulation of T-cell reactivity to 30-kDa secretory protein of Mycobacterium tuberculosis H37Rv and its protective efficacy against experimental tuberculosis.
Journal of medical microbiology 1999;48(8):757-63.
1999: Sudhir Sharma; Indu Verma; Gopal K Khuller
Biochemical interaction of human neutrophil peptide-1 with Mycobacterium tuberculosis H37Ra.
Archives of microbiology 1999;171(5):338-42.
1997: Indu Verma; D Yadav; S Sharma; R Sinha; Sudhir Sharma
Immunoreactivity of mycobacterial 70 kDa protein in different physico-chemical forms.
The Indian journal of medical research 1997;106():13-5.
1997: R K Sinha; Indu Verma; Sudhir Sharma
Immunobiological properties of a 30 kDa secretory protein of Mycobacterium tuberculosis H37Ra.
Vaccine 1997;15(6-7):689-99.
1997: N Dhiman; Indu Verma; Sudhir Sharma
Cellular immune responses to cell wall peptidoglycan associated protein antigens in tuberculosis patients and healthy subjects.
Microbiology and immunology 1997;41(6):495-502.